Navigation Links
PROTEAN II xi Multi-Cell from Bio-Rad

ProductsPROTEAN II xi Multi-Cell from Bio-Rad
Company Bio-Rad
Item PROTEAN II xi Multi-Cell
Price 
Description The PROTEAN II xi multi-cell is for 2-D separations. The cell has a six-gel capacity with efficient cooling capabilities. The PROTEAN II xi multi-cell can be customized for several parameters: gel length, comb, type of glass plates, and cooling system. The PROTEAN II xi multi-cell can also be converted to the PROTEAN II XL multi-cell for a wider format that accommodates 17 and 18 cm IPG strips. PROTEAN II Ready Gel precast slab gels fit this cell.
Info Bio-RadBio-Rad
Bio-Rad Laboratories, Inc.
Life Science Research Group
2000 Alfred Nobel Drive
Hercules, CA 94547
USA
Customer Service: 800-424 6723
Fax Number: 800-879 2289
Web Site: http://discover.bio-rad.com
NOTE: Price information is approximate list price and actual prices may vary.

Related biology products :

1. PROTEAN Plus Overlay Agarose, 125 ml from Bio-Rad
2. PROTEAN II xi Cell, 20 cm, without spacers and combs from Bio-Rad
3. PROTEAN II xi Cell, 16 cm, without spacers and combs from Bio-Rad
4. PROTEAN II XL Cell, wide format from Bio-Rad
5. PROTEAN II XL Cell, wide format, 2.0 mm from Bio-Rad
6. PROTEAN II xi Multi-Cell 2-D Conversion Kit from Bio-Rad
7. PROTEAN II xi Cell 2-D Conversion Kit. from Bio-Rad
8. Mini-PROTEAN II Multiscreen Apparatus from Bio-Rad
9. Mini-PROTEAN II Multiscreen Apparatus from Bio-Rad
10. PROTEAN II xi 2-D Cell from Bio-Rad
11. PROTEAN II Slab Gel Casting Stand, with gaskets from Bio-Rad
Lyophilized. Purity: ≥90% by electrophoresis. Reconstitute in 0.3% NaCl. Prepared from serum that has been shown by certified tests to be negative for HBsAg and for HIV and HCV antibodies. ...
PP2B-Abeta (C-20)...
Goat polyclonal to Duffy / FY / DARC...
... Description: Proteinase K is a highly ... range of applications purified from the fungus T. ... carboxyl group of N-substituted hydrophobic aliphatic and aromatic ... a serine protease. Proteinase K is useful in ...
Biology Products:
(Date:2/21/2017)... February 21, 2017 Der weltweite ... wachsen. Nach einem Gespräch mit mehr als 50 Vertretern aus ... zu überwinden gilt, um diese Prognose zu realisieren. ... ... Mobilisierung der finanziellen Mittel für die Biobank, die Implementierung ...
(Date:2/14/2017)... , Feb. 14, 2017  Wake Forest Baptist ... as its new chief executive officer (CEO). Freischlag joins ... John D. McConnell , M.D., who last year ... at the Medical Center, after leading it since 2008. ... full scope of Wake Forest Baptist,s academic health system, ...
(Date:2/13/2017)... Feb. 13, 2017 Former 9/11 Commission border ... Committee, Janice Kephart of Identity Strategy Partners, ... Donald Trump,s "Executive Order: Protecting the Nation From ... 2017):  "As President Trump,s ,Travel Ban, Executive ... now essentially banned the travel ban, it is important ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... ... March 27, 2017 , ... PMG Research is pleased ... conference presented by The Conference Forum in Boston on April 3-4, 2017. The CTC ... improved clinical trial outcomes and bring them closer to the patient. Clinical Trial Collaborations ...
(Date:3/27/2017)... , March 27, 2017  Trovagene, Inc. (NASDAQ: ... its Chief Executive Officer, Bill Welch , will ... 4, 2017 at 9:00 AM EDT at the Essex ...  Bill Welch, and Chief Scientific Officer, Mark Erlander ... investors during the conference.   The presentation will ...
(Date:3/27/2017)... , March 27, 2017 Neurotrope, ... novel therapies for neurodegenerative diseases, including Alzheimer,s disease, ... its application to list the Company,s common stock ... by The NASDAQ Stock Market, a unit of ... listing, Neurotrope will ring the Opening Bell at the ...
(Date:3/24/2017)... ROCKVILLE, Md. , March 24, 2017 ... Biotech Venture Fund (MBVF), today announced positive results of ... the standard drug therapy regimen in patients with multidrug-resistant ... drug discovered by scientists at Sequella, Inc. ( ... Health. A total of 140 patients ...
Breaking Biology Technology: